GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

racotumomab   Click here for help

GtoPdb Ligand ID: 7995

Synonyms: 1E10 | Vaxira®
Approved drug
racotumomab is an approved drug (Cuba and Argentina (2013))
Compound class: Antibody
Comment: Racotumomab is an anti-idiotype therapeutic cancer vaccine directed against the ganglioside N-glycolil (NGc) GM3 [2,5], which has been identified on the cell surface of malignant cells from lung [4] and breast tumours [8], melanoma [10-11], and neuroectodermal pediatric tumours [6-7,12-13]. Racotumomab is being investigated for its antineoplastic activity.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
Classification Click here for help
Compound class Antibody
Approved drug? Yes. Cuba (2013)  |  Argentina (2013)
International Nonproprietary Names Click here for help
INN number INN
8998 racotumomab
Synonyms Click here for help
1E10 | Vaxira®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 225
Other databases
GtoPdb PubChem SID 249565675
Search PubMed clinical trials racotumomab
Search PubMed titles racotumomab
Search PubMed titles/abstracts racotumomab
Wikipedia Racotumomab